Subscribe to this topic via RSS or ATOM
Topic - David Read
No Stories Found
"When these reports come in we don't know exactly what is going on with the patient," said David Read, regulatory counsel for the FDA's office of generic drugs. "Is it a failure of the drug or is it a coincidence they are experiencing some sort of problem? It's something to discuss between them and their physician."